Sullivan Adam Taylor 4
4 · Core Scientific, Inc./tx · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Sullivan Adam Taylor
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-01-02$14.24/sh−88,380$1,258,796→ 4,128,505 total - Award
Common Stock
2024-12-31+159,306→ 4,216,885 total
Footnotes (2)
- [F1]Represents the acquisition of additional performance-based restricted stock units in connection with the 300% vesting of the first installment of the Reporting Person's performance-based restricted stock units granted on June 14, 2024, and previously reported at 100% vesting in the Form 4 filed by the Reporting Person on June 17, 2024.
- [F2]Represents shares sold to satisfy tax obligations upon the vesting of restricted stock units.